1 completed, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow sarecycline: new trials by email Literature Review of sarecycline trials Research Report on sarecycline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion Therapy Sarecycline Tablet, Placebo tablets of Sarecycline tablets - Ischemic Stroke, Acute | Phase 2 | Unknown | Beijing Tiantan Hospital | 120 | 2023-05-07 | 2023-07-20 |
| Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris 50 mg P005672-HCl, Placebo, 100 mg P005672-HCl - Acne Vulgaris | Phase 2 | Completed | Almirall, S.A. | 285 | 2012-06-30 | 2019-02-01 |
Acne Vulgaris (1) · Ischemic Stroke (1)
Almirall, S.A. (1) · Beijing Tiantan Hospital (1)
China (1) · United States (1)
Herman Ellman, MD (1) · Yilong Wang, PhD,MD (1)
PMID 19834014, PMID 20075087, PMID 26898852, PMID 27733282, PMID 29232823, PMID 29444972, PMID 29601945, PMID 30355104, PMID 31263257, PMID 31296369, PMID 31899551, PMID 32414889, PMID 32568647